OGEN
OGEN
AMEX · Biotechnology

Oragenics Inc

Penny Stocks Biotech Stocks Healthcare Stocks
$0.73
+0.08 (+12.67%)
As of Feb 8, 2:34 PM ET ·
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +602.2% upside
Low Target $3.59
Average Target $5.14
High Target $6.80
Current Price $0.73
Current
$0.73
Target
$5.14
$3.59 $5.14 avg $6.80
Scenario Analysis
Bear Case
$3.59
390.4%
Low target
Base Case
$5.14
+602.2%
Avg target
Bull Case
$6.80
+829.0%
High target
Risk/Reward
2.1x
Favorable
Price in Context
52-Week High
$4.82
-84.8% from high
52-Week Low
$2.19
+-66.6% from low
Target vs 52W High
$5.14
+6.6% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Buy 37 68% $257.58 +15.3%
AMGN
Amgen Inc
 Hold 41 54% $190.87 -50.3%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +137.8%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 77% $438.34 -8.3%
REGN
Regeneron Pharmaceuticals
 Strong Buy 36 75% $76.80 -90.2%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 75% $102.31 -68.8%
INSM
Insmed Inc
 Strong Buy 27 93% $143.40 -4.3%
BIIB
Biogen Inc
 Hold 42 48% $91.45 -54.5%